DiaMedica Therapeutics GAAP EPS of -$0.18 in-line

1 month ago 3

DiaMedica Therapeutics press release (NASDAQ:DMAC): Q1 GAAP EPS of -$0.18 in-line.
Cash Position and Runway – Cash, cash equivalents and short-term investments were $37.3 million as of March 31, 2025, compared to $44.1 million as of December 31, 2024. Based on its current plans, the Company anticipates its current cash, cash

Recommended For You